JANX
Price
$13.76
Change
+$0.04 (+0.29%)
Updated
Jan 16 closing price
Capitalization
827.63M
47 days until earnings call
Intraday BUY SELL Signals
TLPPF
Price
$7.72
Change
+$0.62 (+8.73%)
Updated
Jan 16 closing price
Capitalization
2.57B
Intraday BUY SELL Signals
Interact to see
Advertisement

JANX vs TLPPF

Header iconJANX vs TLPPF Comparison
Open Charts JANX vs TLPPFBanner chart's image
Janux Therapeutics
Price$13.76
Change+$0.04 (+0.29%)
Volume$1.76M
Capitalization827.63M
Telix Pharmaceutical
Price$7.72
Change+$0.62 (+8.73%)
Volume$5.33K
Capitalization2.57B
JANX vs TLPPF Comparison Chart in %
JANX
Daily Signal:
Gain/Loss:
TLPPF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
JANX vs. TLPPF commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and TLPPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (JANX: $13.76 vs. TLPPF: $7.72)
Brand notoriety: JANX and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 79% vs. TLPPF: 145%
Market capitalization -- JANX: $827.63M vs. TLPPF: $2.57B
JANX [@Biotechnology] is valued at $827.63M. TLPPF’s [@Biotechnology] market capitalization is $2.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 1 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • JANX’s FA Score: 1 green, 4 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, both JANX and TLPPF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 4 TA indicator(s) are bullish while TLPPF’s TA Score has 6 bullish TA indicator(s).

  • JANX’s TA Score: 4 bullish, 4 bearish.
  • TLPPF’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, TLPPF is a better buy in the short-term than JANX.

Price Growth

JANX (@Biotechnology) experienced а -2.82% price change this week, while TLPPF (@Biotechnology) price change was -0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

JANX is expected to report earnings on Mar 06, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($2.58B) has a higher market cap than JANX($828M). TLPPF YTD gains are higher at: -0.208 vs. JANX (-0.290). TLPPF has higher annual earnings (EBITDA): 41.7M vs. JANX (-142.22M). JANX has more cash in the bank: 989M vs. TLPPF (207M). JANX has less debt than TLPPF: JANX (22.7M) vs TLPPF (418M). TLPPF has higher revenues than JANX: TLPPF (638M) vs JANX (10M).
JANXTLPPFJANX / TLPPF
Capitalization828M2.58B32%
EBITDA-142.22M41.7M-341%
Gain YTD-0.290-0.208139%
P/E RatioN/A331.10-
Revenue10M638M2%
Total Cash989M207M478%
Total Debt22.7M418M5%
FUNDAMENTALS RATINGS
TLPPF: Fundamental Ratings
TLPPF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JANXTLPPF
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 26 days ago
86%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
71%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
JANX
Daily Signal:
Gain/Loss:
TLPPF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYPCX21.810.17
+0.79%
Nomura Systematic Emerging Markets Eq R
VWYKX50.970.23
+0.45%
Voya Small Cap Growth W
CMCIX25.79-0.02
-0.08%
Calvert Small/Mid-Cap I
CSQCX7.91-0.01
-0.13%
Calvert Global Small-Cap Equity C
PLCGX15.91-0.04
-0.25%
Principal LargeCap Growth I R6

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with AVBP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then AVBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+0.29%
AVBP - JANX
43%
Loosely correlated
-4.75%
SKYE - JANX
41%
Loosely correlated
+3.89%
VIR - JANX
40%
Loosely correlated
-2.26%
UPB - JANX
39%
Loosely correlated
+0.32%
CGON - JANX
37%
Loosely correlated
+3.13%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
+8.73%
GLMD - TLPPF
25%
Poorly correlated
-1.58%
DNLI - TLPPF
24%
Poorly correlated
-4.21%
BEAM - TLPPF
24%
Poorly correlated
-2.59%
RXRX - TLPPF
23%
Poorly correlated
+0.65%
JANX - TLPPF
23%
Poorly correlated
+0.29%
More